← 返回

Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US-Reply.

Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US-Reply.

期刊: JAMA Cardiol 日期: 2026-01-01 PMID: 41920527 DOI: 10.1001/jamacardio.2026.0412 浏览: 67
作者: Khan Sadiya S, Ndumele Chiadi E, Lloyd-Jones Donald M
S, K.S., E, N.C., & M, L.J.D. (2026). Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US-Reply.. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2026.0412
S KS, E NC, M LJD. Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US-Reply.. JAMA Cardiol. 2026; doi: 10.1001/jamacardio.2026.0412
S KS, E NC, M LJD. Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US-Reply.[J]. JAMA Cardiol. 2026. DOI: 10.1001/jamacardio.2026.0412.
@article{s2026,
  author = {Khan Sadiya S and Ndumele Chiadi E and Lloyd-Jones Donald M},
  title = {Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US-Reply.},
  journal = {JAMA Cardiol},
  year = {2026},
  doi = {10.1001/jamacardio.2026.0412},
  note = {PMID: 41920527},
}
TY  - JOUR
AU  - Khan Sadiya S
AU  - Ndumele Chiadi E
AU  - Lloyd-Jones Donald M
TI  - Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US-Reply.
T2  - JAMA Cardiol
PY  - 2026
DO  - 10.1001/jamacardio.2026.0412
AN  - PMID:41920527
ER  - 

摘要

AI 智能解读

相关文献

返回分类: 动脉粥样硬化 查看原文 (DOI)
已选择 0 篇文献